Royalty Pharma plc (RPRX) Income from Non-Controlling Interests (2019 - 2026)
Royalty Pharma (RPRX) recorded Income from Non-Controlling Interests of $63.6 million in Q2 2026, up 5.2% from $60.46 million a year earlier but down 63.4% from the prior quarter.
Powered by 
Analysis
Royalty Pharma plc (RPRX) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
On a TTM basis, Royalty Pharma's Income from Non-Controlling Interests came in at $534.87 million as of Jun 30, 2026, down 17.0% year-over-year; for FY2025, it was $553.25 million, up 17.3% from FY2024.
- Annual Income from Non-Controlling Interests has a five-year compound annual growth rate of -5.3% (FY2020 to FY2025).
- Across earlier years, Income from Non-Controlling Interests came in at $471.83 million in FY2024 (-16.5%), $565.25 million in FY2023 (+201.9%), $187.23 million in FY2022 (-69.9%) and $621.47 million in FY2021 (-14.5%).
- Quarterly Income from Non-Controlling Interests has ranged from -$153.95 million in Q4 2022 to $262.37 million in Q3 2024 over the past five years.
- On a year-over-year basis, Income from Non-Controlling Interests rose in three of the last seven quarters, with growth averaging 44.7%.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 425.1% in Q3 2024, against a decline of 76.6% in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $173.57 million (Q1 2026), $141.71 million (Q4 2025) and $155.99 million (Q3 2025).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63.60 Mn |
| Mar 31, 2026 | 173.57 Mn |
| Dec 31, 2025 | 141.71 Mn |
| Sep 30, 2025 | 155.99 Mn |
| Jun 30, 2025 | 60.46 Mn |
| Mar 31, 2025 | 195.08 Mn |
| Dec 31, 2024 | 126.14 Mn |
| Sep 30, 2024 | 262.37 Mn |
| Jun 30, 2024 | 92.37 Mn |
| Mar 31, 2024 | -9.05 Mn |
| Dec 31, 2023 | 223.25 Mn |
| Sep 30, 2023 | 49.96 Mn |
| Jun 30, 2023 | 123.71 Mn |
| Mar 31, 2023 | 168.33 Mn |
| Dec 31, 2022 | -153.95 Mn |
| Sep 30, 2022 | 77.76 Mn |
| Jun 30, 2022 | 187.09 Mn |
| Mar 31, 2022 | 76.32 Mn |
| Dec 31, 2021 | 45.77 Mn |
| Sep 30, 2021 | 119.87 Mn |
API Access
Royalty Pharma plc Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "RPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=RPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();